![Vincent I. Perrone](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Vincent I.
Perrone is currently the Senior Director-Investor Relations at UroGen Pharma Ltd. He previously worked as the Director-Investor Relations & Communications at Theriva Biologics, Inc.
Postes actifs de Vincent I. Perrone
| Sociétés | Poste | Début |
|---|---|---|
| UROGEN PHARMA LTD. | Investor Relations Contact | 01/01/2022 |
Anciens postes connus de Vincent I. Perrone
| Sociétés | Poste | Fin |
|---|---|---|
| THERIVA BIOLOGICS, INC. | Investor Relations Contact | 01/01/2022 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
27
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Theriva Biologics, Inc.
 Theriva Biologics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes drugs for the treatment of neurological diseases | Health Technology |
UroGen Pharma Ltd.
 UroGen Pharma Ltd. BiotechnologyHealth Technology Develops therapies for urological pathologies | Health Technology |
